Page last updated: 2024-10-16

aminolevulinic acid and Kidney Failure, Chronic

aminolevulinic acid has been researched along with Kidney Failure, Chronic in 7 studies

Aminolevulinic Acid: A compound produced from succinyl-CoA and GLYCINE as an intermediate in heme synthesis. It is used as a PHOTOCHEMOTHERAPY for actinic KERATOSIS.
5-aminolevulinic acid : The simplest delta-amino acid in which the hydrogens at the gamma position are replaced by an oxo group. It is metabolised to protoporphyrin IX, a photoactive compound which accumulates in the skin. Used (in the form of the hydrochloride salt)in combination with blue light illumination for the treatment of minimally to moderately thick actinic keratosis of the face or scalp.

Kidney Failure, Chronic: The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.

Research Excerpts

ExcerptRelevanceReference
"A 72-year-old man with end-stage renal disease (ESRD) undergoing transurethral resection of a bladder tumor experienced severe and prolonged hypotension after receiving oral 5-aminolevulinic acid (5-ALA)."7.96Severe and Prolonged Hypotension After Oral 5-Aminolevulinic Acid Administration in a Patient With End-Stage Renal Disease Undergoing Transurethral Resection of a Bladder Tumor: A Case Report. ( Kida, T; Kobashi, T; Kobayashi, K; Sumitomo, M; Usuda, Y, 2020)
"A 72-year-old man with end-stage renal disease (ESRD) undergoing transurethral resection of a bladder tumor experienced severe and prolonged hypotension after receiving oral 5-aminolevulinic acid (5-ALA)."3.96Severe and Prolonged Hypotension After Oral 5-Aminolevulinic Acid Administration in a Patient With End-Stage Renal Disease Undergoing Transurethral Resection of a Bladder Tumor: A Case Report. ( Kida, T; Kobashi, T; Kobayashi, K; Sumitomo, M; Usuda, Y, 2020)

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19902 (28.57)18.7374
1990's0 (0.00)18.2507
2000's2 (28.57)29.6817
2010's2 (28.57)24.3611
2020's1 (14.29)2.80

Authors

AuthorsStudies
Kida, T1
Kobashi, T1
Usuda, Y1
Kobayashi, K1
Sumitomo, M1
Miyakogawa, T1
Kanai, G1
Tatsumi, R1
Takahashi, H1
Sawada, K1
Kakuta, T1
Fukagawa, M1
Sardh, E1
Andersson, DE1
Henrichson, A1
Harper, P1
Hasuike, Y1
Nonoguchi, H1
Tokuyama, M1
Hata, R1
Kitamura, R1
Hori, K1
Nanami, M1
Otaki, Y1
Kuragano, T1
Nakanishi, T1
Warholm, C1
Wilczek, H1
Day, RS1
Eales, L1
Disler, PB1
Gorchein, A1
Webber, R1

Reviews

1 review available for aminolevulinic acid and Kidney Failure, Chronic

ArticleYear
Porphyrias and the kidney.
    Nephron, 1981, Volume: 28, Issue:6

    Topics: 5-Aminolevulinate Synthetase; Aminolevulinic Acid; Animals; Coproporphyrinogens; Coproporphyrins; He

1981

Other Studies

6 other studies available for aminolevulinic acid and Kidney Failure, Chronic

ArticleYear
Severe and Prolonged Hypotension After Oral 5-Aminolevulinic Acid Administration in a Patient With End-Stage Renal Disease Undergoing Transurethral Resection of a Bladder Tumor: A Case Report.
    A&A practice, 2020, Jan-01, Volume: 14, Issue:1

    Topics: Administration, Oral; Aged; Aminolevulinic Acid; Humans; Hypotension; Kidney Failure, Chronic; Norep

2020
Feasibility of photodynamic therapy for secondary hyperparathyroidism in chronic renal failure rats.
    Clinical and experimental nephrology, 2017, Volume: 21, Issue:4

    Topics: Aminolevulinic Acid; Animals; Biomarkers; Disease Models, Animal; Dose-Response Relationship, Drug;

2017
Porphyrin precursors and porphyrins in three patients with acute intermittent porphyria and end-stage renal disease under different therapy regimes.
    Cellular and molecular biology (Noisy-le-Grand, France), 2009, Feb-16, Volume: 55, Issue:1

    Topics: Adult; Aminolevulinic Acid; Female; Humans; Kidney Failure, Chronic; Middle Aged; Peritoneal Dialysi

2009
Pathological role of aminolevulinate in uremic patients.
    Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy, 2011, Volume: 15, Issue:1

    Topics: Aminolevulinic Acid; Antioxidants; Female; Ferritins; Humans; Hydrogen-Ion Concentration; Iron; Kidn

2011
Renal transplantation in a case of acute intermittent porphyria.
    Journal of clinical pharmacology, 2003, Volume: 43, Issue:10

    Topics: Aminolevulinic Acid; Azathioprine; Creatinine; Cyclosporine; Drug Interactions; Female; Graft Reject

2003
delta-Aminolaevulinic acid in plasma, cerebrospinal fluid, saliva and erythrocytes: studies in normal, uraemic and porphyric subjects.
    Clinical science (London, England : 1979), 1987, Volume: 72, Issue:1

    Topics: Adult; Aminolevulinic Acid; Erythrocytes; Female; Hemin; Humans; Kidney Failure, Chronic; Levulinic

1987